Maria Grazia Refolo

1.4k total citations
30 papers, 992 citations indexed

About

Maria Grazia Refolo is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Maria Grazia Refolo has authored 30 papers receiving a total of 992 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Cancer Research and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Maria Grazia Refolo's work include Cancer, Hypoxia, and Metabolism (6 papers), Gastric Cancer Management and Outcomes (5 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). Maria Grazia Refolo is often cited by papers focused on Cancer, Hypoxia, and Metabolism (6 papers), Gastric Cancer Management and Outcomes (5 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). Maria Grazia Refolo collaborates with scholars based in Italy, Türkiye and Israel. Maria Grazia Refolo's co-authors include Caterina Messa, Rosalba D’Alessandro, Brian I. Carr, Aldo Cavallini, Vito Guerra, Catia Lippolis, Maria Gabriella Caruso, Valeria Tutino, Maria Notarnicola and Francesco Russo and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Nutrients.

In The Last Decade

Maria Grazia Refolo

30 papers receiving 969 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Maria Grazia Refolo Italy	18	459	246	223	175	146	30	992
Kwang Suk Ko South Korea	16	435 0.9×	236 1.0×	125 0.6×	86 0.5×	175 1.2×	47	1.0k
Alvin Wei Tian Ng Singapore	10	429 0.9×	330 1.3×	160 0.7×	135 0.8×	131 0.9×	15	1.0k
Sharad Khare United States	23	761 1.7×	246 1.0×	571 2.6×	123 0.7×	164 1.1×	52	1.6k
Andrea M. A. Pfeifer Switzerland	18	592 1.3×	185 0.8×	274 1.2×	70 0.4×	79 0.5×	24	1.2k
Eagle S.H. Chu Hong Kong	19	677 1.5×	252 1.0×	132 0.6×	234 1.3×	571 3.9×	19	1.3k
Cheng Ma China	17	512 1.1×	142 0.6×	94 0.4×	187 1.1×	320 2.2×	25	1.1k
Stephanie J. Muga United States	17	605 1.3×	157 0.6×	177 0.8×	225 1.3×	126 0.9×	26	1.4k
Takanori Kurokawa Japan	14	309 0.7×	174 0.7×	628 2.8×	91 0.5×	72 0.5×	34	1.3k
Zhi Dai China	20	975 2.1×	370 1.5×	241 1.1×	132 0.8×	653 4.5×	59	1.9k
Sabine M. Klauck Germany	20	955 2.1×	155 0.6×	171 0.8×	72 0.4×	160 1.1×	58	1.6k

Countries citing papers authored by Maria Grazia Refolo

Since Specialization

Citations

This map shows the geographic impact of Maria Grazia Refolo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Grazia Refolo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Grazia Refolo more than expected).

Fields of papers citing papers by Maria Grazia Refolo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Grazia Refolo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Grazia Refolo. The network helps show where Maria Grazia Refolo may publish in the future.

Co-authorship network of co-authors of Maria Grazia Refolo

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Grazia Refolo. A scholar is included among the top collaborators of Maria Grazia Refolo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Grazia Refolo. Maria Grazia Refolo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Franco, Isabella, Antonella Bianco, Giuseppe Riezzo, et al.. (2024). StepFit-18K: Improving Irritable Bowel Syndrome (IBS) Symptoms with a Simple, Structured Walking Intervention. Journal of Clinical Medicine. 13(22). 6684–6684. 2 indexed citations

Tolomeo, Doron, Laura Schirosi, Anna Maria Valentini, et al.. (2023). VEGFA Status as a Predictive Marker of Therapy Outcome in Metastatic Gastric Cancer Patients Following Ramucirumab-Based Treatment. Biomedicines. 11(10). 2721–2721. 3 indexed citations

D’Alessandro, Rosalba, Maria Grazia Refolo, Rossella Donghia, et al.. (2022). Variations in Circulating Levels of Angiopoietin-2 Over Time Are Predictive of Ramucirumab–Paclitaxel Therapy Outcome in Advanced Gastric Cancer: Results of Prospective Study. Frontiers in Oncology. 12. 862116–862116. 4 indexed citations

Notarnicola, Maria, Alberto R. Osella, Maria Gabriella Caruso, et al.. (2021). Nonalcoholic Fatty Liver Disease: Focus on New Biomarkers and Lifestyle Interventions. International Journal of Molecular Sciences. 22(8). 3899–3899. 24 indexed citations

Refolo, Maria Grazia, Claudio Lotesoriere, Caterina Messa, Maria Gabriella Caruso, & Rosalba D’Alessandro. (2020). Integrated immune gene expression signature and molecular classification in gastric cancer: New insights. Journal of Leukocyte Biology. 108(2). 633–646. 29 indexed citations

Refolo, Maria Grazia, Caterina Messa, Vito Guerra, Brian I. Carr, & Rosalba D’Alessandro. (2020). Inflammatory Mechanisms of HCC Development. Cancers. 12(3). 641–641. 147 indexed citations

Refolo, Maria Grazia, Claudio Lotesoriere, Ivan Lolli, Caterina Messa, & Rosalba D’Alessandro. (2020). Molecular mechanisms of synergistic action of Ramucirumab and Paclitaxel in Gastric Cancers cell lines. Scientific Reports. 10(1). 7162–7162. 21 indexed citations

Tutino, Valeria, Valentina De Nunzio, Angela Tafaro, et al.. (2018). Cannabinoid Receptor-1 Up-regulation in Azoxymethane (AOM)-treated Mice After Dietary Treatment with Quercetin. Anticancer Research. 38(8). 4485–4491. 14 indexed citations

D’Alessandro, Rosalba, Maria Grazia Refolo, Catia Lippolis, et al.. (2018). Strong enhancement by IGF1-R antagonists of hepatocellular carcinoma cell migration inhibition by Sorafenib and/or vitamin K1. Cellular Oncology. 41(3). 283–296. 21 indexed citations

10.

D’Alessandro, Rosalba, Maria Grazia Refolo, Catia Lippolis, et al.. (2015). Modulation of Regorafenib effects on HCC cell lines by epidermal growth factor. Cancer Chemotherapy and Pharmacology. 75(6). 1237–1245. 13 indexed citations

11.

Refolo, Maria Grazia, Rosalba D’Alessandro, Natascia Malerba, et al.. (2015). Anti Proliferative and Pro Apoptotic Effects of Flavonoid Quercetin Are Mediated by CB1 Receptor in Human Colon Cancer Cell Lines. Journal of Cellular Physiology. 230(12). 2973–2980. 94 indexed citations

12.

Lippolis, Catia, Maria Grazia Refolo, Rosalba D’Alessandro, et al.. (2015). Resistance to multikinase inhibitor actions mediated by insulin like growth factor-1. Journal of Experimental & Clinical Cancer Research. 34(1). 90–90. 20 indexed citations

13.

D’Alessandro, Rosalba, Caterina Messa, Maria Grazia Refolo, & Brian I. Carr. (2015). Modulation of sensitivity and resistance to multikinase inhibitors by microenvironmental platelet factors in HCC. Expert Opinion on Pharmacotherapy. 16(18). 2773–2780. 14 indexed citations

14.

Refolo, Maria Grazia, Rosalba D’Alessandro, Catia Lippolis, et al.. (2014). Modulation of Doxorubicin Mediated Growth Inhibition of Hepatocellular Carcinoma Cells by Platelet Lysates. Anti-Cancer Agents in Medicinal Chemistry. 14(8). 1154–1160. 7 indexed citations

15.

Carr, Brian I., Aldo Cavallini, Rosalba D’Alessandro, et al.. (2014). Platelet extracts induce growth, migration and invasion in human hepatocellular carcinoma in vitro. BMC Cancer. 14(1). 43–43. 86 indexed citations

16.

D’Alessandro, Rosalba, Maria Grazia Refolo, Catia Lippolis, et al.. (2014). Antagonism of Sorafenib and Regorafenib actions by platelet factors in hepatocellular carcinoma cell lines. BMC Cancer. 14(1). 351–351. 30 indexed citations

17.

Carr, Brian I., Rosalba D’Alessandro, Maria Grazia Refolo, et al.. (2012). Effects of low concentrations of Regorafenib and Sorafenib on human HCC cell AFP, migration, invasion, and growth in vitro. Journal of Cellular Physiology. 228(6). 1344–1350. 50 indexed citations

18.

Carr, Brian I., Aldo Cavallini, Catia Lippolis, et al.. (2012). Fluoro‐Sorafenib (Regorafenib) effects on hepatoma cells: Growth inhibition, quiescence, and recovery. Journal of Cellular Physiology. 228(2). 292–297. 65 indexed citations

19.

Notarnicola, Maria, et al.. (2010). Synergic effect of Eicosapentaenoic acid and Lovastatin on gene expression of HMGCoA reductase and LDL receptor in cultured HepG2 cells. Lipids in Health and Disease. 9(1). 135–135. 46 indexed citations

20.

Linsalata, Michele, Antonella Orlando, Caterina Messa, Maria Grazia Refolo, & Francesco Russo. (2010). Quercetin inhibits human DLD-1 colon cancer cell growth and polyamine biosynthesis.. PubMed. 30(9). 3501–7. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact